🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is looking at outcomes in people with advanced cancers who have ...
Status
Terminated
Location
Peter MacCallum Cancer Centre
Start Date
2021-09-23
Trial ID
NCT04801966
Relative bioavailability study to evaluate the pharmacokinetics of two new ...
Status
Completed
Location
New Haven Clinical Research Unit
Start Date
2022-07-01
Trial ID
NCT05446142
This clinical trial is to clarify whether treatment with a checkpoint inhib...
Status
Recruiting
Location
Herlev Universityhospital
Start Date
2018-06-06
Trial ID
NCT03563729
This is an open-label, unicentre, single-arm Phase 2 study of encorafenib a...
Status
Not Yet Recruiting
Location
Hospital Universitari Vall d'Hebron
Start Date
2025-10
Trial ID
NCT07178717
Treatments Being Tested
StrataPATH™ is a non-randomized, open-label trial designed to explore effic...
Status
Terminated
Location
Florida Cancer Specialists - North
Start Date
2022-04-29
Trial ID
NCT05097599
To evaluate the safety, tolerability and efficacy of LEE011 and LGX818 when...
Status
Terminated
Location
University of Colorado Dept of Oncology
Start Date
2013-07
Trial ID
NCT01777776
The purpose of this clinical trial (called the FLOTILLA study) is to give c...
Status
Recruiting
Location
St. Joseph's Hospital and Medical Center
Start Date
2022-07-05
Trial ID
NCT05203172
The purpose of this first-in-patient, open label study is to determine the ...
Status
Terminated
Location
Mayo Clinic in Arizona - Phoenix
Start Date
2021-03-17
Trial ID
NCT04800822
Treatments Being Tested
To find the recommended dose of ulixertinib that can be given in combinatio...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2024-01-18
Trial ID
NCT05985954
Treatments Being Tested
This is a Phase II, open label, single-arm trial study of adding hydroxychl...
Status
Terminated
Location
Northwestern University
Start Date
2022-10-10
Trial ID
NCT05576896
Treatments Being Tested